MSG
AXSM icon

Main Street Group’s Axsome Therapeutics AXSM Stock Holding History

Main Street Group’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.1K Hold
70
– – ﹤0.01% 477
2026
Q1 		$11.8K Buy
+70
New +$12.1K ﹤0.01% 509

Other funds holding AXSM

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BWP
Baldwin Wealth Partners Marion, Massachusetts $1.53B AUM 28.5% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return
TAM
Tealwood Asset Management Minneapolis, Minnesota $261M AUM 52.68% 1-Year Est. Return

Main Street Group's AXSM Position: Q2 2026 in Review

Main Street Group held its Axsome Therapeutics (AXSM) position steady in Q2 2026 at 70 shares worth $17.1K. The position accounts for ﹤0.01% of the portfolio, ranked #477.

Main Street Group first reported a position in AXSM in Q1 2026 and has held it in 2 quarters since. 53 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • Main Street Group held 70 shares of Axsome Therapeutics worth $17.1K as of Q2 2026.
  • Main Street Group left its Axsome Therapeutics share count unchanged in Q2 2026.
  • Axsome Therapeutics made up ﹤0.01% of Main Street Group's portfolio in Q2 2026, its #477 holding.
  • Main Street Group first reported a position in Axsome Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 53 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on Main Street Group's 13F filing for Q2 2026, filed 13 Jul 2026.